Company page

Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd. (ASX: ATX) is a public company based in Australia, focusing on the development of innovative therapies for cancer and fibrotic diseases. With a market capitalization of approximately AUD 52.1 million, Amplia is dedicated to advancing its drug candidates through clinical trials. The company aims to address significant unmet medical needs in the healthcare sector.